With NRAS, KRAS, PTPN11, and KMT2D, we detected variants in genes that were shown to be mutated in low frequencies in blast crisis, but to a lower extent also in chronic phase CML (52). The gene discussed is KMT2D; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.